These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meningococcal vaccine. Med Lett Drugs Ther; 1974 Aug; 16(18):74-5. PubMed ID: 4212159 [No Abstract] [Full Text] [Related]
3. Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease. Frøholm LO NIPH Ann; 1980 Dec; 3(2):67-74. PubMed ID: 6784045 [No Abstract] [Full Text] [Related]
5. A novel method to screen genomic libraries that combines genomic immunization with the prime-boost strategy. Yero D; Pajón R; Caballero E; González S; Cobas K; Fariñas M; Lopez Y; Acosta A FEMS Immunol Med Microbiol; 2007 Aug; 50(3):430-3. PubMed ID: 17537176 [TBL] [Abstract][Full Text] [Related]
6. Change in recommendation for meningococcal vaccine for travelers. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1999 Feb; 48(5):104. PubMed ID: 10084899 [No Abstract] [Full Text] [Related]
7. Vaccine research: new vaccines and evidence of vaccine safety. Commun Dis Rep CDR Wkly; 1999 May; 9(19):167, 170. PubMed ID: 10334064 [No Abstract] [Full Text] [Related]
8. Neisseria meningitidis in the 1990s. King WJ; MacDonald NE Adv Pediatr Infect Dis; 1997; 13():143-64. PubMed ID: 9544311 [No Abstract] [Full Text] [Related]
9. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock]. Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172 [TBL] [Abstract][Full Text] [Related]
10. Commentary: prophylaxis for contacts of patients with meningococcal disease. Gold R Pediatr Infect Dis; 1982; 1(2):139-40. PubMed ID: 6817315 [No Abstract] [Full Text] [Related]
11. Vaccination against meningococcal disease. Griffiss JM N Engl J Med; 1983 Jun; 308(23):1421. PubMed ID: 6405276 [No Abstract] [Full Text] [Related]
12. Development of polysaccharide vaccines for the prevention of meningococcal diseases. Gotschlich EC Monogr Allergy; 1975; 9():245-58. PubMed ID: 804088 [No Abstract] [Full Text] [Related]
14. Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine. Bremner C; Lennon D; Martin D; Baker M; Rümke H N Z Med J; 1999 Jul; 112(1091):257-9. PubMed ID: 10448985 [No Abstract] [Full Text] [Related]
15. [Experience with the immunoprophylaxis of meningococcal infection in military collectives]. Efimov EI Voen Med Zh; 1989 Apr; (4):49. PubMed ID: 2503934 [No Abstract] [Full Text] [Related]
16. [Immunoprophylaxis of meningococcal infection among the troops]. Khokhlov DT; Efimov EI Voen Med Zh; 1984 Oct; (10):51-3. PubMed ID: 6438904 [No Abstract] [Full Text] [Related]
18. Present status of polysaccharide vaccines in the prevention of meningococcal disease. Gold R; Lepow ML Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651 [No Abstract] [Full Text] [Related]
19. [Meningococcal infections: vaccination and prevention by drugs]. Herzog C Ther Umsch; 1983 Mar; 40(3):239-43. PubMed ID: 6407135 [No Abstract] [Full Text] [Related]
20. Meningococcal protein antigens and vaccines. Feavers IM; Pizza M Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]